Please wait...
About This Project
OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Birds eavesdrop on plant indirect defenses to locate insect preys
We all know that birds have a great vision, right? But what if they could also smell?! We demonstrated...
Where are all the Diamondback terrapins on Cumberland Island?
There is no previous population study that exists on the Diamondback terrapins of Cumberland Island, Georgia...
Transforming Styrofoam waste into biodegradable plastic
The primary objective of the project is to create an industrially-comparable method of producing PHA, a...
